South San Francisco, CA · Founded 2010 · Privately Held (backing)
Operator of a biotechnology firm intended to develop therapies that improve the body's healing response and repair damaged tissue. Silver Creek Pharmaceuticals is based in South San Francisco, CA and was founded in 2010. Its last reported valuation was $60 million in Feb 2018. It has raised $57.1 million across 2 recorded rounds; the latest was a $9.2 million early-stage round in Jan 2022.
Last reported valuation
$60.0M
Oct 2026
Priced at
—
Total raised
$57.1M
Last round
Early Stage VC
Jan 2022
Cap table — not yet on record
Silver Creek Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Silver Creek Pharmaceuticals with a free account
·Watch Silver Creek Pharmaceuticals: the Monday email on marks, rounds and moves
Frequently asked about Silver Creek Pharmaceuticals
Where does Silver Creek Pharmaceuticals's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Silver Creek Pharmaceuticals's 2 recorded funding rounds.
